Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Papastergiou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Histology and Histopathology|September 9, 2022
Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort datasetIoanna Maria Grypari, Ioanna Pappa, Thomas Papastergiou, et al.
Journal of Integrative Bioinformatics|July 27, 2023
Discovering NDM-1 inhibitors using molecular substructure embeddings representationsThomas Papastergiou, Jérôme Azé, Sandra Bringay, et al.
Blood Advances|October 7, 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnosticAurélie Montagne, Gildas Bertho, Thomas Papastergiou, et al.
Therapeutic Advances in Medical Oncology|September 15, 2022
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre studyFoteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Histology and Histopathology|September 9, 2022
Elucidating the role of PRMTs in prostate cancer using open access databases and a patient cohort datasetIoanna Maria Grypari, Ioanna Pappa, Thomas Papastergiou, et al.
Journal of Integrative Bioinformatics|July 27, 2023
Discovering NDM-1 inhibitors using molecular substructure embeddings representationsThomas Papastergiou, Jérôme Azé, Sandra Bringay, et al.
Blood Advances|October 7, 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnosticAurélie Montagne, Gildas Bertho, Thomas Papastergiou, et al.
Therapeutic Advances in Medical Oncology|September 15, 2022
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre studyFoteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, Petros Christopoulos, et al.
Pageof 1